Literature DB >> 24632354

Adjusting to a seizure-free "new normal" life following discontinuation of antiepileptic drugs during adolescence.

Ya-Ping Chiu1, Tzu-Ying Lee2, Kuang-Lin Lin3, Virginia L Laadt4.   

Abstract

This qualitative study sought to understand how children in adolescence adjust to their newly acquired normal life without epilepsy, following discontinuation of antiepileptic drugs during this dynamic period of growth and development. Three major themes with subthemes were identified: 1) setting the body and mind free; 2) engaging in self-regulation; and 3) protection by significant others. A sense of relief from constraints related to treatment schedules, special diets, and avoiding seizure-provoking activities was expressed by all participants. Freedom from side effects of the antiepileptic drugs improved life at home and school. Most of the participants said that they were not worried about seizure recurrence but would use caution against a possible relapse. Family members also must adjust to a new lifestyle. Medical staff needs to provide support and adequate care to adolescents during their period of identity adjustment following antiepileptic drug discontinuation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescents; Antiepileptic drug; Discontinuation; Seizure-free

Mesh:

Substances:

Year:  2014        PMID: 24632354     DOI: 10.1016/j.yebeh.2014.02.009

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  1 in total

1.  Making Decisions About Stopping Medicines for Well-Controlled Juvenile Idiopathic Arthritis: A Mixed-Methods Study of Patients and Caregivers.

Authors:  Daniel B Horton; Jomaira Salas; Aleksandra Wec; Melanie Kohlheim; Pooja Kapadia; Timothy Beukelman; Alexis Boneparth; Ky Haverkamp; Melissa L Mannion; L Nandini Moorthy; Sarah Ringold; Marsha Rosenthal
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-03       Impact factor: 4.794

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.